(Q34666872)

3 August 2017

1 reference

title

The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women (English)

1 reference

Hormone Replacement Therapy

3 August 2017

1 reference

1 reference

1 reference

Mary Seed

1

1 reference

3 August 2017

publication date

1 May 2002

1 reference

Atherosclerosis. Supplements

3 August 2017

published in

1 reference

3 August 2017

volume

3

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

53-63

1 reference

Menopause and coronary heart disease. The Framingham Study

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Menopause and risk factors for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Influence of age and menopause on serum lipids and lipoproteins in healthy women.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Metabolism of apolipoproteins A-I and A-ll and its influence on the high density lipoprotein subfraction distribution in males and females

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

L-norgestrel and progesterone have different influences on plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Triglyceride removal efficiency and lipoprotein lipases: effects of Oxandrolone

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Regional differences in arterial low density lipoprotein metabolism in surgically postmenopausal cynomolgus monkeys. Effects of estrogen and progesterone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Estrogen modulates responses of atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Short-term administration of estrogen and vascular responce of atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Oestrogens and atherosclerotic vascular disease--local vascular factors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Syndrome X in women is associated with oestrogen deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Induction of calcium-dependent nitric oxide synthases by sex hormones.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Premenopausal determinants of menopausal estrogen use.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Hormone replacement therapy and intima-media thickness of the common carotid artery: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Less heat, more light

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Postmenopausal use of estrogen and occlusion of coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Risk factors and noncontraceptive estrogen use in women with and without coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Postmenopausal estrogen use and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900009-5

7 January 2021

10.1016/S1567-5688(01)00009-5

Identifiers

DOI

1 reference

3 August 2017

1 reference